GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

Telehealth companies are promoting GLP-1 medications such as Ozempic and Wegovy for cosmetic weight loss in non-obese patients, despite FDA limitations on their approved use, according to a Nov. 24 ...

FAT jabs could harm mum and baby if taken too close to pregnancy, a study suggests. Women who used the GLP-1 injections, such ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

MONDAY, Nov. 24, 2025 (HealthDay News) — Eli Lilly reached a major milestone Friday, becoming the first healthcare company in ...

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the ...

Aanu Adeoye So, Bayer’s drug called asundexian is intended for people who have suffered something called a non-cardioembolic stroke, or people who have suffered a mini stroke, because people who have ...

Eli Lilly LLY secured a significant milestone on Friday when it became the first company in the healthcare space to reach $1 ...

Researchers note that MASLD not only harms the liver. The condition is strongly linked with other metabolic complications, including heart disease, stroke, and certain cancers. For some, it can ...

Lilly's $1T valuation and soaring GLP-1 demand spotlight ETFs like IHE, PPH, MEDI, OZEM, MEDX and THNR for investors riding ...